ESR1 and breast carcinoma: In three subtypes (ER+ MCF7, HER2+ SK-BR-3, triple negative HCC1806 and MDA-MB-231 cells) of human breast cancer cell lines, ATRA alone was not able to modulate cell cycle regulators.